MedTrace Logo

Oxytocin and Human Defensive Responses in a Dynamic Situation

NCT07162584 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-10-06

No results posted yet for this study

Summary

The presnet study is to investigate the effect of intranasal oxytocin (24 IU) treatment on modulating how human responsd to threat in a dynamic situation.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin nasal spray

intranasal administration of oxytocin (24 IU)

DRUG

Placebo

intranasal administration of placebo (24 IU)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Shuxia Yao, Dr · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-13
Primary Completion
2026-01-15
Completion
2026-01-28

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07162584 on ClinicalTrials.gov